OBJECTIVE: There is limited understanding about what treatment decision making (TDM) means to patients. The study objective was to identify any processes or stages of TDM as perceived by women with early stage breast cancer (ESBC). METHODS: Initial consultations with a surgeon or medical oncologist were videotaped. Subsequently, women viewed their consultation using a qualitative approach with video-stimulated recall (VSR) interviews. Interviews were taped, transcribed, and analyzed. RESULTS: There were 6 surgical and 15 medical oncology (MO) consultations. Most women described TDM as beginning soon after diagnosis and involving several processes including gathering information from informal and formal networks and identifying preferred treatment options before the specialist consultation. Many women wanted more information from their surgeon so they could engage in subsequent TDM with their medical oncologist. CONCLUSION: In this study, women with ESBC began TDM soon after diagnosis and used several iterative processes to arrive at a decision about their cancer treatment. VSR interviews can be useful to investigate TDM occurring during the consultation. PRACTICE IMPLICATIONS: Women with ESBC rely on information provided by their surgeons and family physicians to make treatment decisions about surgery and also to prepare them for subsequent discussions with medical oncologists about chemotherapy.
OBJECTIVE: There is limited understanding about what treatment decision making (TDM) means to patients. The study objective was to identify any processes or stages of TDM as perceived by women with early stage breast cancer (ESBC). METHODS: Initial consultations with a surgeon or medical oncologist were videotaped. Subsequently, women viewed their consultation using a qualitative approach with video-stimulated recall (VSR) interviews. Interviews were taped, transcribed, and analyzed. RESULTS: There were 6 surgical and 15 medical oncology (MO) consultations. Most women described TDM as beginning soon after diagnosis and involving several processes including gathering information from informal and formal networks and identifying preferred treatment options before the specialist consultation. Many women wanted more information from their surgeon so they could engage in subsequent TDM with their medical oncologist. CONCLUSION: In this study, women with ESBC began TDM soon after diagnosis and used several iterative processes to arrive at a decision about their cancer treatment. VSR interviews can be useful to investigate TDM occurring during the consultation. PRACTICE IMPLICATIONS: Women with ESBC rely on information provided by their surgeons and family physicians to make treatment decisions about surgery and also to prepare them for subsequent discussions with medical oncologists about chemotherapy.
Authors: Mary Ann O'Brien; Peter M Ellis; Timothy J Whelan; Cathy Charles; Amiram Gafni; Peter Lovrics; Som D Mukherjee; Nicole Hodgson Journal: Health Expect Date: 2011-09-16 Impact factor: 3.377
Authors: M A O'Brien; J C Carroll; D P Manca; B Miedema; P A Groome; T Makuwaza; J Easley; N Sopcak; L Jiang; K Decker; M L McBride; R Moineddin; J A Permaul; R Heisey; E A Eisenhauer; M K Krzyzanowska; S Pruthi; C Sawka; N Schneider; J Sussman; R Urquhart; C Versaevel; E Grunfeld Journal: Curr Oncol Date: 2017-04-27 Impact factor: 3.677
Authors: Christopher E Cox; Carmen L Lewis; Laura C Hanson; Catherine L Hough; Jeremy M Kahn; Douglas B White; Mi-Kyung Song; James A Tulsky; Shannon S Carson Journal: Crit Care Med Date: 2012-08 Impact factor: 7.598
Authors: Mary Ann O'Brien; Cathy Charles; Timothy J Whelan; Peter M Ellis; Amiram Gafni; Peter Lovrics Journal: Support Care Cancer Date: 2013-01-24 Impact factor: 3.603
Authors: Ken Resnicow; Paul Abrahamse; Rachel S Tocco; Sarah Hawley; Jennifer Griggs; Nancy Janz; Angela Fagerlin; Adrienne Wilson; Kevin C Ward; Sheryl G A Gabram; Steven Katz Journal: BMC Med Inform Decis Mak Date: 2014-12-05 Impact factor: 2.796